|
EP1361273A3
(en)
|
1992-11-24 |
2004-02-11 |
G.D. Searle & Co. |
Interleukin-3 (IL-3) multiple mutation polypeptides
|
|
GB9225453D0
(en)
|
1992-12-04 |
1993-01-27 |
Medical Res Council |
Binding proteins
|
|
ES2156149T3
(es)
|
1992-12-04 |
2001-06-16 |
Medical Res Council |
Proteinas de union multivalente y multiespecificas, su fabricacion y su uso.
|
|
AU680685B2
(en)
|
1993-09-22 |
1997-08-07 |
Medical Research Council |
Retargeting antibodies
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US6171820B1
(en)
|
1995-12-07 |
2001-01-09 |
Diversa Corporation |
Saturation mutagenesis in directed evolution
|
|
US6562594B1
(en)
|
1999-09-29 |
2003-05-13 |
Diversa Corporation |
Saturation mutagenesis in directed evolution
|
|
US7011812B1
(en)
|
1996-05-03 |
2006-03-14 |
Immunomedics, Inc. |
Targeted combination immunotherapy of cancer and infectious diseases
|
|
EP0954340B1
(en)
|
1996-05-03 |
2007-06-27 |
Immunomedics, Inc. |
Targeted combination immunotherapy of cancer
|
|
US5922845A
(en)
|
1996-07-11 |
1999-07-13 |
Medarex, Inc. |
Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies
|
|
US20030207346A1
(en)
|
1997-05-02 |
2003-11-06 |
William R. Arathoon |
Method for making multispecific antibodies having heteromultimeric and common components
|
|
US20020062010A1
(en)
|
1997-05-02 |
2002-05-23 |
Genentech, Inc. |
Method for making multispecific antibodies having heteromultimeric and common components
|
|
US7951917B1
(en)
|
1997-05-02 |
2011-05-31 |
Genentech, Inc. |
Method for making multispecific antibodies having heteromultimeric and common components
|
|
ATE299938T1
(de)
|
1997-05-02 |
2005-08-15 |
Genentech Inc |
Ein verfahren zur herstellung multispezifischer antikörper die heteromultimere und gemeinsame komponenten besitzen
|
|
WO1999048527A1
(en)
|
1998-03-27 |
1999-09-30 |
Genentech, Inc. |
Apo-2 ligand-anti-her-2 antibody synergism
|
|
US7833528B2
(en)
|
1998-06-22 |
2010-11-16 |
Immunomedics, Inc. |
Use of multispecific, non-covalent complexes for targeted delivery of therapeutics
|
|
DE60129741T2
(de)
|
2000-06-20 |
2008-04-30 |
Immunomedics, Inc. |
Zielgerichtete kombinationsimmuntherapie für krebs und infektionskrankheiten
|
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
|
US8034903B2
(en)
|
2000-10-20 |
2011-10-11 |
Chugai Seiyaku Kabushiki Kaisha |
Degraded TPO agonist antibody
|
|
AU2002250081A1
(en)
|
2001-02-14 |
2002-08-28 |
Uab Research Foundation |
Combined transductional and transcriptional targeting system for improved gene delivery
|
|
DE60327199D1
(de)
|
2002-04-26 |
2009-05-28 |
Chugai Pharmaceutical Co Ltd |
Verfahren zum screening auf agonistische antikörper
|
|
AU2013200009B2
(en)
|
2002-07-18 |
2015-05-07 |
Merus N.V. |
Recombinant production of mixtures of antibodies
|
|
US8337841B2
(en)
|
2003-01-21 |
2012-12-25 |
Chugai Seiyaku Kabushiki Kaisha |
Methods of screening for antibody light chains
|
|
JP4794301B2
(ja)
|
2003-06-11 |
2011-10-19 |
中外製薬株式会社 |
抗体の製造方法
|
|
US20090191213A9
(en)
|
2003-07-02 |
2009-07-30 |
Novo Nordisk A/S |
Compositions and methods for regulating NK cell activity
|
|
WO2005030793A2
(en)
|
2003-09-24 |
2005-04-07 |
Millennium Pharmaceuticals, Inc. |
Antibodies which bind human cxcr3
|
|
US7235641B2
(en)
|
2003-12-22 |
2007-06-26 |
Micromet Ag |
Bispecific antibodies
|
|
GB0329825D0
(en)
|
2003-12-23 |
2004-01-28 |
Celltech R&D Ltd |
Biological products
|
|
US20050266425A1
(en)
|
2003-12-31 |
2005-12-01 |
Vaccinex, Inc. |
Methods for producing and identifying multispecific antibodies
|
|
AU2005313971B2
(en)
|
2004-12-08 |
2011-10-13 |
Immunomedics, Inc. |
Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer
|
|
EP1699826B1
(en)
|
2005-01-05 |
2009-03-11 |
f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. |
Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions
|
|
WO2006074399A2
(en)
|
2005-01-05 |
2006-07-13 |
Biogen Idec Ma Inc. |
Multispecific binding molecules comprising connecting peptides
|
|
AU2006232287B2
(en)
|
2005-03-31 |
2011-10-06 |
Chugai Seiyaku Kabushiki Kaisha |
Methods for producing polypeptides by regulating polypeptide association
|
|
EP2230256A1
(en)
|
2005-09-23 |
2010-09-22 |
Walter Reed Army Institute of Research (WRAIR) |
Antibodies with simultaneous subsite specificities to protein and lipid epitopes
|
|
EP1940881B1
(en)
|
2005-10-11 |
2016-11-30 |
Amgen Research (Munich) GmbH |
Compositions comprising cross-species-specific antibodies and uses thereof
|
|
NZ615012A
(en)
|
2006-03-21 |
2015-11-27 |
Genentech Inc |
Combinatorial therapy involving alpha5beta1 antagonists
|
|
WO2008027236A2
(en)
|
2006-08-30 |
2008-03-06 |
Genentech, Inc. |
Multispecific antibodies
|
|
GB0620729D0
(en)
|
2006-10-18 |
2006-11-29 |
Ucb Sa |
Biological products
|
|
BRPI0813645A2
(pt)
|
2007-06-25 |
2014-12-30 |
Esbatech Alcon Biomed Res Unit |
Métodos para modificar anticorpos, e anticorpos modificados com propriedades funcionais aperfeiçoadas
|
|
KR20100058509A
(ko)
|
2007-07-31 |
2010-06-03 |
메디뮨 엘엘씨 |
다중특이적 에피토프 결합 단백질 및 이의 용도
|
|
KR20100052545A
(ko)
|
2007-08-28 |
2010-05-19 |
바이오겐 아이덱 엠에이 인코포레이티드 |
Ｉｇｆ―１ｒ의 다중 에피토프에 결합하는 조성물
|
|
MY151191A
(en)
|
2007-09-26 |
2014-04-30 |
Genentech Inc |
Novel antibodies
|
|
EP2113255A1
(en)
|
2008-05-02 |
2009-11-04 |
f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. |
Cytotoxic immunoglobulin
|
|
KR102050040B1
(ko)
|
2008-06-25 |
2019-11-28 |
에스바테크 - 어 노바티스 컴파니 엘엘씨 |
ＴＮＦα를 저해하는 안정한 가용성 항체
|
|
JP2011526792A
(ja)
|
2008-07-02 |
2011-10-20 |
エマージェント プロダクト デベロップメント シアトル， エルエルシー |
ＴＮＦ−αアンタゴニスト多重標的結合性タンパク質
|
|
MX2011000071A
(es)
|
2008-07-02 |
2011-05-03 |
Emergent Product Dev Seattle |
Inmunoterapeuticos de interleucina-6 (il6).
|
|
NZ590667A
(en)
|
2008-07-02 |
2013-01-25 |
Emergent Product Dev Seattle |
Tgf-b antagonist multi-target binding proteins
|
|
US20110130324A1
(en)
|
2008-07-14 |
2011-06-02 |
Uchicago Argonne, Llc |
Methods for systematic control of protein stability
|
|
CA2732574A1
(en)
|
2008-07-28 |
2010-02-04 |
Philip Tan |
Multi-specific binding proteins targeting b cell disorders
|
|
NO2344540T3
(enExample)
|
2008-10-02 |
2018-04-28 |
|
|
|
MY152068A
(en)
|
2009-03-20 |
2014-08-15 |
Genentech Inc |
Bispecific anti-her antibodies
|
|
CA2756244A1
(en)
|
2009-04-02 |
2010-10-07 |
Roche Glycart Ag |
Multispecific antibodies comprising full length antibodies and single chain fab fragments
|
|
CA2773515C
(en)
|
2009-09-29 |
2015-04-28 |
Roche Glycart Ag |
Bispecific death receptor agonistic antibodies
|
|
CN102711811A
(zh)
|
2009-10-30 |
2012-10-03 |
拜耳医药保健有限公司 |
抗体模拟物支架
|
|
CN102770456B
(zh)
|
2009-12-04 |
2018-04-06 |
弗·哈夫曼-拉罗切有限公司 |
多特异性抗体、抗体类似物、组合物和方法
|
|
CA2785907A1
(en)
|
2009-12-29 |
2011-07-28 |
Emergent Product Development Seattle, Llc |
Ron binding constructs and methods of use thereof
|
|
SMT202600080T1
(it)
|
2010-02-08 |
2026-03-09 |
Regeneron Pharma |
Topo con catena leggera comune
|
|
WO2011109726A2
(en)
|
2010-03-05 |
2011-09-09 |
Bioatla Llc |
Homologous multi-specific antibodies
|
|
KR101860963B1
(ko)
|
2010-04-23 |
2018-05-24 |
제넨테크, 인크. |
이종다량체 단백질의 생산
|
|
ES2741175T3
(es)
|
2010-07-16 |
2020-02-10 |
Bioatla Llc |
Nuevos métodos de evolución de proteínas
|
|
CN103261220B
(zh)
|
2010-08-16 |
2016-06-15 |
诺夫免疫股份有限公司 |
用于生成多特异性和多价抗体的方法
|
|
MX349622B
(es)
|
2010-09-08 |
2017-08-07 |
Halozyme Inc |
Metodos para evaluar e identificar o evolucionar proteinas terapeuticas condicionalmente activas.
|
|
TWI452136B
(zh)
|
2010-11-17 |
2014-09-11 |
中外製藥股份有限公司 |
A multiple specific antigen-binding molecule that replaces the function of Factor VIII in blood coagulation
|
|
ME02734B
(me)
|
2011-01-14 |
2017-10-20 |
Ucb Biopharma Sprl |
Antitelo koje vezuje il-17a i il-17f
|
|
EP2500073A1
(en)
|
2011-03-17 |
2012-09-19 |
ChromaCon AG |
Method for identification and purification of multi-specific polypeptides
|
|
WO2012158818A2
(en)
|
2011-05-16 |
2012-11-22 |
Fabion Pharmaceuticals, Inc. |
Multi-specific fab fusion proteins and methods of use
|
|
KR102060389B1
(ko)
*
|
2011-05-21 |
2019-12-31 |
마크로제닉스, 인크. |
사람 및 비-사람 cd3에 결합할 수 있는 cd3-결합 분자
|
|
WO2013003647A2
(en)
|
2011-06-28 |
2013-01-03 |
Sea Lane Biotechnologies, Llc |
Multispecific stacked variable domain binding proteins
|
|
UA117901C2
(uk)
|
2011-07-06 |
2018-10-25 |
Ґенмаб Б.В. |
Спосіб посилення ефекторної функції вихідного поліпептиду, його варіанти та їх застосування
|
|
EP2543680A1
(en)
|
2011-07-07 |
2013-01-09 |
Centre National de la Recherche Scientifique |
Multispecific mutated antibody Fab fragments
|
|
EP2760891B1
(en)
|
2011-09-26 |
2018-11-07 |
JN Biosciences LLC |
Hybrid constant regions
|
|
HUE033245T2
(hu)
*
|
2011-12-19 |
2017-11-28 |
Synimmune Gmbh |
Bispecifikus ellenanyag molekula
|
|
EP2825553B1
(en)
*
|
2012-03-14 |
2018-07-25 |
Regeneron Pharmaceuticals, Inc. |
Multispecific antigen-binding molecules and uses thereof
|
|
US20150086584A1
(en)
|
2012-03-22 |
2015-03-26 |
University Of Miami |
Multi-specific binding agents
|
|
AU2013259276B2
(en)
|
2012-05-10 |
2018-03-22 |
Bioatla Llc |
Multi-specific monoclonal antibodies
|
|
MX2014014162A
(es)
|
2012-05-24 |
2015-02-04 |
Hoffmann La Roche |
Anticuerpos multiespecificos.
|
|
JP2015524821A
(ja)
|
2012-08-02 |
2015-08-27 |
ジェイエヌ バイオサイエンシーズ エルエルシー |
システイン変異及びμ尾部を介して多量体化した抗体又は融合タンパク質
|
|
KR20140036905A
(ko)
|
2012-09-18 |
2014-03-26 |
삼성전자주식회사 |
이중특이 항체를 포함하는 단백질 복합체
|
|
GB201223276D0
(en)
|
2012-12-21 |
2013-02-06 |
Ucb Pharma Sa |
Antibodies and methods of producing same
|
|
CN105722859B
(zh)
|
2013-07-25 |
2021-05-07 |
西托姆克斯治疗公司 |
多特异性抗体、多特异性可活化抗体及其使用方法
|
|
EP2840091A1
(en)
|
2013-08-23 |
2015-02-25 |
MacroGenics, Inc. |
Bi-specific diabodies that are capable of binding gpA33 and CD3 and uses thereof
|
|
CA2955947A1
(en)
|
2014-07-25 |
2016-01-28 |
Cytomx Therapeutics, Inc. |
Anti-cd3 antibodies, activatable anti-cd3 antibodies, multispecific anti-cd3 antibodies, multispecific activatable anti-cd3 antibodies, and methods of using the same
|
|
JP6871155B2
(ja)
*
|
2014-07-25 |
2021-05-12 |
メモリアル スローン ケタリング キャンサー センター |
二重特異性ｈｅｒ２及びｃｄ３結合分子
|
|
MX2017006016A
(es)
|
2014-11-11 |
2017-06-19 |
Amunix Operating Inc |
Composiciones conjugadas de xten direccionadas y metodos para producir las mismas.
|
|
CA2973040A1
(en)
*
|
2015-01-09 |
2016-07-14 |
Mabimmune Diagnostics Ag |
Novel anti-fibroblast activation protein (fap) antibodies and uses derived thereof
|
|
EP3262217A4
(en)
*
|
2015-02-24 |
2018-07-18 |
BioAtla LLC |
Conditionally active biological proteins
|
|
WO2017078839A1
(en)
*
|
2015-11-02 |
2017-05-11 |
Bioatla, Llc |
Conditionally active polypeptides
|
|
AU2016378573A1
(en)
*
|
2015-12-22 |
2018-07-19 |
Regeneron Pharmaceuticals, Inc. |
Bispecific anti-CD20/anti-CD3 antibodies to treat acute lymphoblastic leukemia
|
|
JP2019512263A
(ja)
|
2016-02-22 |
2019-05-16 |
オーシャンサイド バイオテクノロジー |
免疫療法におけるネオ抗原組成物及び同組成物を使用する方法
|
|
WO2017167350A1
(en)
|
2016-03-30 |
2017-10-05 |
Horst Lindhofer |
Multispecific antibodies for use in the treatment of a neoplasm of the urinary tract
|
|
SMT202600033T1
(it)
|
2016-04-15 |
2026-03-09 |
Bioatla Inc |
Anticorpi anti-axl, frammenti di anticorpo e loro immunoconiugati e loro utilizzi
|
|
WO2017201731A1
(en)
*
|
2016-05-27 |
2017-11-30 |
Beijing Vdjbio Co., Ltd. |
Antibodies, composition and kits comprising same, and methods of use thereof
|
|
US9567399B1
(en)
|
2016-06-20 |
2017-02-14 |
Kymab Limited |
Antibodies and immunocytokines
|
|
AU2017320874B2
(en)
*
|
2016-08-31 |
2024-03-07 |
Bioatla, Llc |
Conditionally active polypeptides and methods of generating them
|
|
WO2019241216A1
(en)
*
|
2018-06-14 |
2019-12-19 |
Bioatla, Llc |
Multi-specific antibody constructs
|
|
US20250313630A1
(en)
*
|
2022-05-27 |
2025-10-09 |
Bighat Biosciences, Inc. |
Ph-selective anti-cd3 antibodies and use of the same
|